MDK and central nervous system cancer: In addition to the mechanisms discussed above, recent studies have revealed that MDK can signal through the ALK receptor to sustain the self‐renewal and tumorigenic capacity of glioma‐initiating cells and that this pathway may contribute to temozolomide resistance.17